|
SPATA5L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.84730000005484E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82970000156746E-08 |
| Normal-vs-Stage2 |
2.197500E-02 |
| Normal-vs-Stage3 |
2.137400E-01 |
| Normal-vs-Stage4 |
1.183360E-01 |
| Stage1-vs-Stage2 |
5.023000E-01 |
| Stage1-vs-Stage3 |
1.556070E-03 |
| Stage1-vs-Stage4 |
9.721600E-02 |
| Stage2-vs-Stage3 |
1.431200E-01 |
| Stage2-vs-Stage4 |
4.743800E-01 |
| Stage3-vs-Stage4 |
5.467000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.433950E-04 |
| Normal-vs-AfricanAmerican |
7.787400E-04 |
| Normal-vs-Asian |
8.655800E-02 |
| Caucasian-vs-AfricanAmerican |
4.976100E-02 |
| Caucasian-vs-Asian |
2.008800E-01 |
| AfricanAmerican-vs-Asian |
6.849000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.881800E-03 |
| Normal-vs-Female |
6.92180002204168E-09 |
| Male-vs-Female |
1.410860E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.447400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.8714999999967E-05 |
| Normal-vs-Age(61-80Yrs) |
8.2055999999997E-05 |
| Normal-vs-Age(81-100Yrs) |
3.828200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.344400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.241800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.566400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.025200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.281600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.018000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.427400E-04 |
| Normal-vs-Grade 2 |
3.06720000509131E-08 |
| Normal-vs-Grade 3 |
1.003130E-03 |
| Normal-vs-Grade 4 |
1.012980E-01 |
| Grade 1-vs-Grade 2 |
4.169600E-02 |
| Grade 1-vs-Grade 3 |
2.196900E-03 |
| Grade 1-vs-Grade 4 |
3.83070000053998E-07 |
| Grade 2-vs-Grade 3 |
2.623700E-02 |
| Grade 2-vs-Grade 4 |
9.55299994664927E-09 |
| Grade 3-vs-Grade 4 |
1.221420E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.57651669496772E-14 |
| Normal-vs-ccB subtype |
3.610000E-01 |
| ccA subtype-vs-ccB subtype |
3.33066907387547E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.591300E-04 |
| Normal-vs-N1 |
6.534200E-01 |
| N0-vs-N1 |
9.852300E-02 |
|
|
